Ready to unlock your cells’ potential?
No other team is as dedicated to advancing cell culture media as Multus.
Talk to our media specialists today!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No other team is as dedicated to advancing cell culture media as Multus.
Talk to our media specialists today!
Advanced cell and gene therapies require specialized media for novel cell types: from stem cells and NK cells to AAV production and CAR-T manufacturing. Traditional media development takes 2-4 years and costs millions of dollars per formulation, creating a critical barrier to manufacturing scale-up and patient access. These prohibitive costs and timelines prevent breakthrough therapies from reaching commercial scale and the patients who need them.
Our MediOPTM platform accelerates media development for the diverse cell types used in advanced therapies, from early-stage research through commercial manufacturing. We help you overcome the cost and timeline barriers that prevent therapeutic innovations from reaching patients.
Custom media development tailored to your therapeutic cell type. From rapid Express screening and Boost optimization of existing formulations to complete De Novo design, our platform addresses the specific challenges of stem cells, immune cells, and viral production systems.
Learn more
Seamless transition from optimized formulation to GMP-like production. Our global partner network ensures you can access therapeutic-grade media at clinical and commercial scales.
Learn more
Formulations tailored to your therapeutic cell type's unique requirements, optimized for viability, potency, and consistency in manufacturing.
Deliver optimized media in weeks instead of years, at a fraction of traditional costs.
Flexible development pathways from catalog screening to complete custom design, matching your development stage and clinical timeline requirements.
As a partner on a project, I can say that the Multus team has been fantastic, very responsive, helpful in providing additional information about their media when requested and able to accommodate even last-minute requests. Working with them has been a blast! Also their media formulation is easy to prepare and it comes with clear instructions.
Petra Hanga
Co-founder and CSO, Quest Meat
The Multus media development team are extremely efficient and knowledgable and have taken the hassle out of the complex media optimization process. We’ve seen impressive formulation results in a short period of time due to their innovative and high-throughput media development pipeline.
Dr. Olivia Ogilvie
CEO, Opo Bio
Multus have provided custom media manufacturing for us and have been a reliable, responsive supplier.
Tom Phillips
Chief Commercial Officer, Roslintech
Our media specialists understand the unique challenges of cellular agriculture scale-up. Schedule a consultation to discuss your cell line, food-grade regulatory requirements, and cost reduction targets.
